Revascularisation for Ischaemic Cardiomyopathy
Interventional Cardiology: Reviews, Research, Resources · 01.08.2023 · 18
DOI: 10.15420/icr.2023.06 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Interventional Cardiology: Reviews, Research, Resources, online erschienen am 01.08.2023. Verfasst von Matthew E Li Kam Wa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Coronary Research Group, British Heart Foundation Centre of Research Excellence, King's College London London, UK. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Coronary artery disease is a leading cause of heart failure with reduced ejection fraction. Coronary artery bypass grafting appears to provide clinical benefits such as improvements in quality of life, reductions in readmissions and MI, and favourable effects on long-term mortality; however, there is a significant short-term procedural risk when left ventricular function is severely impaired, which poses a conundrum for many patients. Could percutaneous coronary intervention provide the same benefits without the hazard of surgery? There have been no randomised studies to support this practice until recently. The REVIVED-BCIS2 trial (NCT01920048) assessed the outcomes of percutaneous coronary intervention in addition to optimal medical therapy in patients with ischaemic left ventricular dysfunction and stable coronary artery disease. This review examines the trial results in detail, suggests a pathway for investigation and revascularisation in ischaemic cardiomyopathy, and explores some of the remaining unanswered questions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Coronary Research Group, British Heart Foundation Centre of Research Excellence, King's College London London, UK.
- Division of Cardiology, Columbia University Irving Medical Center/New York-Presbyterian Hospital New York, NY, US.
- Cardiovascular Research Foundation New York, NY, US.
- Cardiovascular Division, Guy's and St Thomas' NHS Foundation Trust London, UK.
Zitieren
APA
Li Kam Wa, M. E., Assar, S. Z., Kirtane, A. J., & Perera, D. (2023). Revascularisation for Ischaemic Cardiomyopathy. Interventional Cardiology: Reviews, Research, Resources, 18. https://doi.org/10.15420/icr.2023.06
Vancouver
Li Kam Wa ME, Assar SZ, Kirtane AJ, Perera D. Revascularisation for Ischaemic Cardiomyopathy. Interventional Cardiology: Reviews, Research, Resources. 2023;18. doi:10.15420/icr.2023.06
BibTeX
@article{LiKamWa2023,
author = {Li Kam Wa, Matthew E and Assar, Saba Z and Kirtane, Ajay J and Perera, Divaka},
title = {Revascularisation for Ischaemic Cardiomyopathy},
journal = {Interventional Cardiology: Reviews, Research, Resources},
year = {2023},
volume = {18},
doi = {10.15420/icr.2023.06}
}
EUVIMED